Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,976 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00319800 | Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC | unknown | Phase 2 | 50 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| NCT00502762 | Topotecan for Irinotecan-Refractory SCLC | unknown | Phase 2 | — | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2008 | clinicaltrials |
| Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck Dissection |
| completed |
| Phase 2 |
| 200 |
| Asan Medical CenterOTHER |
| 1 |
| Mar 6, 2008 |
| clinicaltrials |
| NCT00625352 | Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma | unknown | Phase 2 | 48 | Ulsan University HospitalOTHER | 1 | Feb 28, 2008 | clinicaltrials |
| NCT00580359 | S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer | unknown | Phase 2 | 96 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 8, 2008 | clinicaltrials |
| NCT00515190 | Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma | unknown | Phase 2 | 198 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00587145 | Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer | unknown | Phase 2 | 44 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00561301 | Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma | unknown | Phase 2 | 43 | Cooperative Study Group A for HematologyNETWORK | 1 | Nov 20, 2007 | clinicaltrials |
| NCT00436423 | A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer | completed | Phase 2 | 38 | Korea University Anam HospitalOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00539669 | TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian | completed | Phase 2 | 47 | SanofiINDUSTRY | 1 | Oct 4, 2007 | clinicaltrials |
| NCT00529880 | Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML | unknown | Phase 2 | 19 | Cooperative Study Group A for HematologyNETWORK | 1 | Sep 27, 2007 | clinicaltrials |
| NCT00509964 | Second-Line Irinotecan vs. ILF for AGC | unknown | Phase 2 | 50 | Gachon University Gil Medical CenterOTHER | 1 | Aug 1, 2007 | clinicaltrials |
| NCT00510107 | Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC | unknown | Phase 2 | 90 | Gachon University Gil Medical CenterOTHER | 1 | Aug 1, 2007 | clinicaltrials |
| NCT00506168 | Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer | terminated | Phase 2 | 37 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506571 | Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer(TIROX2) | unknown | Phase 2 | 42 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506623 | Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer | unknown | Phase 2 | 48 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506844 | Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer(ERBIRIX) | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00490399 | Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas | completed | Phase 2 | 39 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 22, 2007 | clinicaltrials |
| NCT00320294 | ILF With/Without Cisplatin for Advanced Gastric Cancer | unknown | Phase 2 | 86 | Gachon University Gil Medical CenterOTHER | 1 | Mar 12, 2007 | clinicaltrials |
| NCT00425022 | VATS Lobectomy for Clinical Stage IB or II Lung Cancer | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 30, 2007 | clinicaltrials |
| NCT00190801 | Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 186 | Eli Lilly and CompanyINDUSTRY | 8 | Jan 26, 2007 | clinicaltrials |
| NCT00329498 | L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes | suspended | Phase 2 | 25 | Samsung Medical CenterOTHER | 1 | Oct 26, 2006 | clinicaltrials |
| NCT00378755 | Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM | unknown | Phase 2 | 62 | Korean Multiple Myeloma Working PartyOTHER | 1 | Sep 22, 2006 | clinicaltrials |
| NCT00373620 | A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients | unknown | Phase 2 | 50 | Korean Gynecologic Oncology GroupOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00319865 | PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma | unknown | Phase 2 | 47 | Korean Multiple Myeloma Working PartyOTHER | 1 | Apr 27, 2006 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials